Position in ALGS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,431,370
-$699,562 QoQ
Shares Held
327,237
-2.6% QoQ
Ownership
9.12%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALGS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sio Capital Management, LLC holds $315,732,064 across 42 Biotechnology names. ALGS ranks #31 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
370,045 | $31,054,176 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
674,759 | $27,199,535 | |
| 3 | TYRA |
Tyra Biosciences, Inc.
|
605,439 | $23,188,313 | |
| 4 | CELC |
Celcuity Inc.
|
193,843 | $22,125,240 | |
| 5 | ABVX |
Abivax S.A.
|
135,800 | $15,121,330 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
1,498,620 | $13,427,635 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
294,340 | $11,800,090 | |
| 8 | RAPP |
Rapport Therapeutics, Inc.
|
366,809 | $11,477,453 |
All Filings in ALGS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,431,370 | 327,237 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,130,932 | 335,937 | Shares | Sole | 2026-02-11 | |
| 2025-12-31 | $3,130,932 | 335,937 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,292,182 | 335,937 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,422,105 | 335,937 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,490,940 | 180,720 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||